You can buy or sell NDRA and other stocks, options, ETFs, and crypto commission-free!
ENDRA Life Sciences, Inc. engages in the development of ultrasound technology for the pre-clinical research market. It develops Thermo-Acoustic Enhanced UltraSound platform to enable clinicians to visualize human tissue composition, function and temperature. Read More The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.
Ann Arbor, Michigan
52 Week High
52 Week Low
Seeking AlphaMar 11
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q4 2018 Results - Earnings Call Transcript
ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q4 2018 Earnings Conference Call March 11, 2019 4:30 PM ET Company Participants Chris Tyson - Managing Director, MZ North America Francois Michelon - CEO David Wells - CFO Michael Thornton - Chief Technology Officer Conference Call Participants Kyle Bauser - Dougherty and Company Brooks O'Neil - Lake Street Capital Markets Paul Bienstock - National Securities Michael Brcic - National Securities Bill Morrison - National Securities Bruce Jackson - The Benchma...
Stock Price, News, & Analysis for ENDRA Life Sciences
ENDRA Life Sciences Inc. develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding. It also offers the Nexus-128 system that combines light-based the...
-$0.28 per share